Physician profile
Barry Thomas Tarpley
NPI 1659474534
$9,164.09
in general payments reported to CMS, 2019-2025
47 companies · $37.67 in 2025
The $37.67 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,155 · 2020: $1,256 · 2021: $2,224 · 2022: $2,013 · 2023: $1,089 · 2024: $1,388 · 2025: $37.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,515.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,568.94 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $923.76 | 2021-2024 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $848.45 | 2019-2024 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $743.16 | 2019-2024 | Repatha, Otezla, Evenity |
| Amarin Pharma, INC. | $485.44 | 2020-2022 | |
| Lilly USA, LLC | $439.69 | 2019-2024 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $411.87 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $411.33 | 2019-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $323.14 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $294.78 | 2019-2023 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $281.72 | 2019-2024 | Xifaxan, Trulance |
| Janssen Pharmaceuticals, INC | $211.97 | 2019-2024 | Xarelto, Spravato |
| Abbott Laboratories | $209.19 | 2021-2024 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $186.53 | 2019-2024 | Verquvo, Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $179.95 | 2021-2023 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Tarpley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.